A decision support model for cost-effectiveness of radical prostatectomy in localized prostate cancer

References

• Kvale R, Auvinen A, Adami HO, Klint A, Hernes E, Moller B, Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst 2007;99:1881–7.
   PubMed Web of Science ®Google Scholar
• Ung JO, Richie JP, Chen MH, Renshaw AA, D'Amico AV. Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era. Urology 2002;60:458–63.
   PubMed Web of Science ®Google Scholar
• Klotz L, Zhang LY, Lam A, Nam R, Mamedov A, Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010;28:126–31.
   PubMed Web of Science ®Google Scholar
• Shortliffe EH. Medical informatics: computer applications in health care and biomedicine. 2nd ed. New York: Springer; 2001.
   Google Scholar
• Griffin S, Claxton K, Hawkins N, Sculpher M. Probabilistic analysis and computationally expensive models: necessary and required? Value Health 2006;9:244–52.
   PubMed Web of Science ®Google Scholar
• Hummel S, Paisley S, Morgan A, Currie E, Brewer N. Clinical and cost-effectiveness of new and emerging technologies for early localised prostate cancer: a systematic review. Health Technol Assess 2003;7(33):iii, ix–x, 1–157.
   PubMedGoogle Scholar
• Calvert NW, Morgan AB, Catto JWF, Hamdy FC, Akehurst RL, Mouncey P, Effectiveness and cost-effectiveness of prognostic markers in prostate cancer. Br J Cancer 2003;88:31–5.
   PubMed Web of Science ®Google Scholar
• Kattan MW, Cowen ME, Miles BJ. A decision analysis for treatment of clinically localized prostate cancer. J Gen Intern Med 1997;12:299–305.
   PubMed Web of Science ®Google Scholar
• Scandinavian Prostatic Cancer Group. Expectant management or radical prostatectomy for early prostatic cancer (T0d–T2, NX, MO, G1–2): a multicentre study. SPCG-4. http://www.roc.se/prostata/spcg4.pdf.
   Google Scholar
• Holmberg L, Bill-Axelson A, Helgesen F, Salo JO, Folmerz P, Haggman M, A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002;347:781–9.
   PubMed Web of Science ®Google Scholar
• Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S, Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005;352:1977–84.
   PubMed Web of Science ®Google Scholar
• Bill-Axelson A, Holmberg L, Filen F, Ruutu M, Garmo H, Busch C, Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian Prostate Cancer Group-4 randomized trial. J Natl Cancer Inst 2008;100:1144–54.
   PubMed Web of Science ®Google Scholar
• Bill-Axelson A, Holmberg L, Ruutu M, Garmo H, Stark JR, Busch C, Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2011;364:1708–17.
   PubMed Web of Science ®Google Scholar
• Johansson E, Bill-Axelson A, Holmberg L, Onelov E, Johansson JE, Steineck G, Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting:the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial. Eur Urol 2009;55:422–32.
   PubMed Web of Science ®Google Scholar
• Steineck G, Helgesen F, Adolfsson J, Dickman PW, Johansson J, Norlen BJ, Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 2002;347:790–6.
   PubMed Web of Science ®Google Scholar
• Andersson SO, Andrén O, Lyth J, Stark J, Henriksson M, Adami HO, Managing localized prostate cancer by radical prostatectomy or watchful waiting: cost analysis of a randomized trial (SPCG-4). Scand J Urol Nephrol 2011;45:177–83.
   PubMed Web of Science ®Google Scholar
• Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. A decision-analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA 1993;269:2650–8.
   PubMed Web of Science ®Google Scholar
• Armitage P, Berry G. Statistical methods in medical research. 3rd ed. Oxford:Blackwell Scientific Publications; 1994.
   Google Scholar
• Kirkwood BR, Sterne JAC. Essential medical statistics. 2nd ed. Malden, MA: Blackwell Science; 2003.
   Google Scholar
• Briggs A, Sculpher M, Dawson J, Fitzpatrick R, Murray D, Malchau H. Modelling the cost-effectiveness of primary hip replacement: how cost-effective is the Spectron compared to the Charnley prosthesis? Technical Report CHE Technical Paper Series 28. York: Centre for Health Economics; 2003.
   Google Scholar
• Statistics Sweden. http://www.scb.se.
   Google Scholar
• Nelder JA, Wedderburn RWM. Generalized linear models. JRStatSoc A 1972;135:370–84.
   Google Scholar
• Olsson U. Generalized linear models: an applied approach. Lund: Studentlitteratur; 2002.
   Google Scholar
• Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 1999;18:341–64.
   PubMed Web of Science ®Google Scholar
• Claxton K, Sculpher M, Drummond M. A rational framework for decision making by the National Institute for Clinical Excellence (NICE). Lancet 2002;360:711–15.
   PubMed Web of Science ®Google Scholar
• The National Prostate Cancer Register (NPCR) in Sweden 2004–2008. http://www.vinkcancer.se/Global/Diagnoser/prostatacancer/rapporter/prostataca_rapport_04_08.pdf.
   Google Scholar